Sara Harrysson

9PUBLICATIONS
47CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Feb 04, 2026
Incidence, timing, and prognosis of heart failure after treatment for large B-cell lymphoma in Sweden during 2007-2022.

Sissel Johanne Godtfredsen, Fanny Bergström, Sara Harrysson

|Apr 23, 2025
Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies.

Sara Harrysson, Sandra Eloranta, Stefanie Antonilli

|Dec 22, 2023
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy.

Sara Harrysson, Sandra Eloranta, Sara Ekberg

|Jul 18, 2022
Excellent survival after R-Hyper-CVAD in hospitalized patients with high-risk large B-cell lymphoma: The Karolinska experience.

Kristina Sonnevi, Maria Ljungqvist, Jóel Kristinn Jóelsson

|Apr 25, 2022
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients.

Sara Harrysson, Sandra Eloranta, Sara Ekberg

Pageof 2

Frequent Collaborators

4 joint publications

Sandra Eloranta

2 joint publications

Sara Ekberg

2 joint publications

Mats Jerkeman

2 joint publications

Karin E Smedby